MarketCapTrends
ALT

Altimmune, Inc. (ALT)

NASDAQ · Healthcare

Altimmune, Inc. annual/quarterly total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Altimmune, Inc. total liabilities for the quarter ending December 31, 2025 were 55.0M, a 248.38% increase year-over-year.
  • Altimmune, Inc. total liabilities for 2025 were 55.0M, a 248.38% increase from 2024.
  • Altimmune, Inc. total liabilities for 2024 were 15.8M, a 4.49% decrease from 2023.
  • Altimmune, Inc. total liabilities for 2023 were 16.5M, a 23.55% decrease from 2022.
  • Altimmune, Inc. total liabilities for 2022 were 21.6M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Altimmune, Inc. Annual Total Liabilities (Millions of US $)
2025$55
2024$16
2023$17
2022$22
2021$20
2020$19
2019$9
2018$6
2017$14
2016$6
2011$7
2010$15
Altimmune, Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$55
2024-12-31$16
2023-12-31$17
2022-12-31$22
2021-12-31$20
2020-12-31$19
2019-12-31$9
2018-12-31$6
2017-12-31$14
2016-12-31$6
2011-12-31$7
2010-12-31$15

Altimmune, Inc. Total Liabilities — FAQ

Altimmune, Inc. (ALT) total liabilities over the last 12 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ALT's total liabilities history?

The chart and table above show Altimmune, Inc.'s total liabilities by year and by quarter, including the growth rate.